Use of a formulation of immediate release with an active ingredient selected from pramipexole hydrochloride, pramipexole,Pramipexole dihydrochloride Monohydrate or a pharmaceutically acceptable Salt, for the treatment of the sick

摘要

The present invention refers to the use of pramipexole, pramipexole hydrochloride, pramipexole dihydrochloride or pramipexole dihydrochloride monohydrate for the manufacture of a medicament for the treatment of early Parkinson's disease by a maintenance, twice daily application.